Enhancing linkage to care for hepatitis B, D, and C patients : A retrospective-prospective study
Vargas-Accarino, Elena (Vall d'Hebron Institut de Recerca (VHIR))
Rando-Segura, Ariadna (Hospital Universitari Vall d'Hebron)
Palom, Adriana (Vall d'Hebron Institut de Recerca (VHIR))
Feliu-Prius, Anna (Vall d'Hebron Institut de Recerca (VHIR))
Martínez-Campreciós, Joan (Vall d'Hebron Institut de Recerca (VHIR))
Barreira-Diaz, Ana (Vall d'Hebron Institut de Recerca (VHIR))
Romero-Vico, Judith (Vall d'Hebron Institut de Recerca (VHIR))
Ruiz Cobo, Juan Carlos (Vall d'Hebron Institut de Recerca (VHIR))
Llaneras Artigues, Jordi (Vall d'Hebron Institut de Recerca (VHIR))
Riveiro Barciela, Mar (Universitat Autònoma de Barcelona. Departament de Medicina)
Rodríguez Frías, Francisco (Vall d'Hebron Institut de Recerca (VHIR))
Esteban, Rafael (Vall d'Hebron Institut de Recerca (VHIR))
Buti, Maria (Universitat Autònoma de Barcelona. Departament de Medicina)

Data:	2024
Resum:	Background: The WHO has set a goal to decrease viral hepatitis-related fatalities by 65% by 2030. Aims: To locate and retrieve to care all individuals diagnosed with hepatitis B, D or C, and investigate why they were not linked to appropriate medical management. Methods: We conducted a retrospective-prospective search for patients with hepatitis B, D or C virus (HBV, HDV and HCV) infection in the central laboratory database of the Barcelona northern health area (catchment population, 450,000). We reviewed records and contacted candidates for retrieval who were offered a specialist medical visit. Results: We reviewed records of 3731 patients with viral hepatitis (January 2019-December 2022): 1763 HBsAg+, 69 anti-HDV+ and 1899 HCV-RNA+. Among these, 644 (37%) HBV, 20 (29%) HDV and 1116 (56%) HCV patients were not currently linked to care. The proportion of patients receiving appropriate care was higher in HBV and HDV (p < 0. 0001), and a higher percentage of unlinked hepatitis C patients had low life expectancy/comorbidities (39%; p < 0. 0001). After implementing the linkage strategy, 254 HBV, 16 HDV and 54 HCV patients were successfully reintegrated into care. Among 1780 patients requiring linkage, 638 (35. 8%) had moved to another health area or were missing essential contact data. Conclusions: Among patients with viral hepatitis who required appropriate specialist care and were eligible for contact, 64% with HBV, 100% with HDV and 27% with HCV were successfully reintegrated into care. Overall, 324 (47. 2%) eligible patients were linked to care, indicating the success of this strategy.
Ajuts:	Instituto de Salud Carlos III PI23/01065
Nota:	Altres ajuts: acords transformatius de la UAB
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Publicat a:	Alimentary pharmacology & therapeutics, Vol. 60, Num. 10 (November 2024) , p. 1308-1314, ISSN 1365-2036

DOI: 10.1111/apt.18227

7 p, 1.4 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats